Tirzepatide is a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://imogenllqq076065.is-blog.com/47478528/tirzepatide-a-new-frontier-in-diabetes-treatment